Akiko (AKIKO)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 174.86% and profit growth of 258.91% indicate strong recent momentum.
• Latest quarter sales of ₹51 Cr and net profit of ₹6 Cr show the business is currently operating at scale.
• PEG ratio of 0.08 suggests valuation is low relative to recent growth rates.
• Promoter holding of 67.29% aligns management incentives with minority shareholders.
• Piotroski F-Score of 6/9 points to reasonably sound fundamentals despite missing data.

Concerns

• No book value, ROE, or debt/equity data makes it impossible to assess margin of safety or capital efficiency.
• Reported ROCE of 0.00% is a red flag for a financial services business unless the reported data is misleading.
• Zero dividend yield means no income support while waiting for uncertain future growth.
• Small market cap of ₹235 Cr and a 52-week range of ₹123–₹368 expose investors to sharp volatility and potential liquidity issues.

AI Analysis

At ₹223.20, Akiko carries a market cap of only ₹235 crore. That is small, and in a financial services name, I demand a clear picture of underlying value. Here I don't have it: no book value, no return on equity, and ROCE reported as 0.00%. Benjamin Graham taught me to measure the balance sheet before paying for growth. Without those numbers, I cannot call this a margin-of-safety purchase. What I do see is remarkable momentum. Sales grew 174.86% and profits grew 258.91%; the latest quarter shows ₹51 crore in sales and ₹6 crore in net profit. A PEG ratio of 0.08 suggests the market is pricing in far slower growth than the current trajectory, but that ratio can mislead when base effects are small. The Piotroski score of 6/9 is acceptable but not outstanding. Promoters own 67.29%, which aligns interests, though the free float is limited and price swings can be sharp. The 52-week range of ₹123 to ₹368 tells me this stock can move violently; today's price sits far below the high and well above the low. There is no dividend, so all returns must come from capital appreciation. In the Buffett style, I would say: wait for more data, demand access to book value and return metrics, and do not extrapolate 175% sales growth forever. This is a fast grower, but a fast grower without a visible balance sheet is a speculation, not an investment, unless the next few quarters confirm durability. I will watch whether growth generates real cash, whether margins hold, and whether the equity base justifies this valuation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer